Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers...
Policy + Market Dual Windfall, Cosunter's Innovative Pipeline Long-term Value Highlights
Innovative drug concept stocks rapidly plummeted, with NEPTUNUS hitting the daily limit, RemeGen falling more than 10%, and many stocks including Cosunter, Rundu Pharma, Sunshine Guojian Pharmaceutical, SL PHARM, and HITECK dropping more than 6%
The three major A-share indices all closed higher
The three major A-share indices closed mixed, with media stocks rising
Cosunter: Net loss of RMB 44.8963 million in the third quarter, a decrease of 29.75%
Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million yuan